2023-03-24 09:49:43
Latest Post
W S Industries India Ltd approves availing of short term loans
SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor
Stock Report
Fredun Pharmaceuticals Ltd Q3 FY2023 PAT increases to Rs. 3.45 crore
Posted On : 2023-01-27 20:30:52( TIMEZONE : IST )
Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 77.9559 crores during the period ended December 31, 2022 as compared to Rs. 70.3227 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 3.4567 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 3.1527 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 7.66 for the period ended December 31, 2022 as compared to Rs. 7.11 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹77.9559 crs | ₹70.3227 crs |  10.85% |
| Net Profit | ₹3.4567 crs | ₹3.1527 crs | 9.64% |
| EPS | ₹7.66 | ₹7.11 | 7.74% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.77.9559 crores during the period ended December 31, 2022 as compared to Rs.54.2325 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.3.4567 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.1.8716 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.7.66 for the period ended December 31, 2022 as compared to Rs.4.22 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹77.9559 crs | ₹54.2325 crs | 43.74% |
| Net Profit | ₹3.4567 crs | ₹1.8716 crs | 84.69% |
| EPS | ₹7.66 | ₹4.22 | 81.52% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.77.9559 crores during the 9 Months period ended December 31, 2022 as compared to Rs.154.2443 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.3.4567 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.4.0396 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.7.66 for the 9 Months period ended December 31, 2022 as compared to Rs.10.13 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹77.9559 crs | ₹154.2443 crs |  -49.46% |
| Net Profit | ₹3.4567 crs | ₹4.0396 crs | -14.43% |
| EPS | ₹7.66 | ₹10.13 | -24.38% |
Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 989.00 as compared to the previous close of Rs. 999.30. The total number of shares traded during the day was 2909 in over 170 trades.
The stock hit an intraday high of Rs. 1010.00 and intraday low of 972.00. The net turnover during the day was Rs. 2872216.00.
